Nonspecific migraine acute treatment

Migraine and Other Headache Disorders

Volumn , Issue , 2016, Pages 273-288

  Krymchantowski, Abouch ^a   Tepper, Stewart J ^b,c  

^a Headache Center of Rio   (Brazil)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62349132450     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (104)

1. Dodick DW. Acute and prophylactic management of migraine. Clin Cornerstone 2001; 4:36-52.
2. Tfelt-Hansen P, Lipton RB. Prioritizing treatment. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press, 1993:359-362.
3. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002; 346:257-270.
4. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002; 42(suppl 1):3-9.
5. Limmroth V, Przywara S. Analgesics. In: Diener HC, ed. Drug Treatment of Migraine and Other Headaches. Monogr Clin Neurosci 2000; 17:30-43.
6. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache 2002; 42(9):862-871.
7. Tfelt-Hansen P, Olesen J. Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine. Eur Neurol 1980; 19:163-165.
8. Limmroth V, Katsarava Z, Diener H-C. Acetylsalicylic acid in the treatment of headache. Cephalalgia 1999; 19:545-551.
9. Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN. Aspirin is efficacious for the treatment of acute migraine. Headache 2005; 45(4):283-292.
10. Diener HC, Bussone G, de Liano H, et al. EMSASI Study Group. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 2004; 24(11):947-954.
11. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A Study to Compare Oral Sumatriptan with Oral Aspirin plus Metoclopramide in the Acute Treatment of Migraine. Eur Neurol 1992; 32:177-184.
12. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995; 346:923-926.
13. Diener HC for the ASASUMAMIG Study Group. The efficacy and safety of Acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the cute treatment of migraine. A double-blind, double-dummy, randomized multicenter parallel group study. Cephalalgia 1999; 19(6):581-588.
14. Silberstein SD, for the US Headache Consortium. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:754-763.
15. Goldstein J, Hoffman HD, Armellino JJ, et al. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine. Cephalalgia 1999; 19:684-691.
16. Silberstein SD, Armellino JJ, Hoffman HD, et al. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther 1999; 21(3):475-491.
17. Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeullerie G. Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalalgia 1994; 14:156-161.
18. Dexter SR, Graham AN, Johnson ES, Ratcliffe EM, Wilkinson MIP, Rose AJ. Doubleblind controlled study of Paramax in the acute treatment of common and classical migraine. Br J Clin Pract 1985; 39:388-392.
19. Diamond S. Treatment of migraine with isometheptene, acetaminophen and dichlorphenazone combination: a double-blind, cross-over trial. Headache 1976; 16: 282-287.
20. Peatfield RC, Petty RG, Rose FC. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia 1983; 3:129-134.
21. MacGregor EA, Wilkinson M, Bancroft K. Domperidone plus paracetamol in the treatment of migraine. Cephalalgia 1993; 13:124-127.
22. Hakkaranainen H, Gustafsson B, Stockman O. A comparative trial of ergotamine tartrate, acetylsalicylic acid and a dextropropoxyphene compound in acute migraine attacks. Headache 1978; 18:35-39; Hakkaranainen H, Parantainen J, Gothoni G, Vapaatalo H. Tolfenamic acid and caffeine: a useful combination in migraine. Cephalalgia 1982; 2:173-177.
23. Hakkaranainen H, Vapaatalo H, Gothoni G, Parantainen J. Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet 1979; 2:326-328.
24. Myllyla VV, Havanka H, Herrala L, et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache 1998; 38:201-207.
25. Johnson ES, Ratcliffe DM, Wilkinson M. Naproxen sodium in the treatment of migraine. Cephalalgia 1985; 5:5-10.
26. Nestvold K, Kloster R, Partinen M, Sulkava R. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 1985; 5:115-119.
27. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache 1989; 29:507-509.
28. Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992; 12:169-171.
29. Sandrini G, Franchini S, Lanfranchi S, Granella F, Manzoni GC, Nappi G. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. Int J Clin Pharmacol Res 1998; 18:145-150.
30. Hamalainen ML, Hoppu K, Valkeila E, Santavuore P. Ibuprofeno or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, cross-over study. Neurology 1997; 48:103-107.
31. Awidi AS. Efficacy of flurbiprofen in the treatment of acute migraine attacks: a doubleblind cross-over study. Curr Ther Res 1982; 32:492-497.
32. Guidotti M, Zanasi S, Garagiola U. Pirprofen in the treatment of migraine and episodic headache attacks: a placebo-controlled cross-over clinical trial. J Int Med Res 1989; 17:48-54.
33. Kangasneimi P, Kaaja R. Ketoprofen and ergotamine in acute migraine. J Intern Med 1992; 231:551-554.
34. Massiou H, Serrurier D, Lassere O, Bousser MG. Effectiveness of oral diclofenac in the acute treatment of common migraine attacks; a double-blind study versus placebo. Cephalalgia 1991; 11,59-63.
35. Dahlof C, Bjorkman R. Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine. Cephalalgia 1993; 13:117-123.
36. Del Bene E, Poggioni M, Garagiola U, Maresca V. Intramuscular treatment of migraine attacks using diclofenac sodium: a cross-over clinical trial. J Int Med Res 1987; 15:44-48.
37. Krymchantowski AV, Barbosa JS, Cheim C, Alves LA. Oral lysine clonixinate in the acute treatment of migraine: a double-blind, placebo-controlled study. Arq Neuropsiquiatr 2001; 59:46-49.
38. Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997; 53(1):139-88.
39. Davis CP, Torre PR, Williams C, et al. Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients. Am J Emerg Med 1995; 13: 145-150.
40. Duarte C, Dunaway F, Turner L, Aldag J, Frederick R. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial. Ann Emerg Med 1992; 21:1116-1121.
41. Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac versus chlorpromazine in the treatment of acute migraine without aura. A prospective randomized double-blind trial. Arch Intern Med 1996; 156:1725-1728.
42. Meredith JT, Wait S, Brewer KL. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med 2003; 21(3):173-175.
43. Maliekal J, Elboim CM. Gastrointestinal complications associated with intramuscular ketorolac tromethamine therapy in the elderly. Ann Pharmacother 1995; 29:698-701.
44. Traversa G, Walker AM, Ippolito FM, et al. Gastrointestinal toxicity of different nonsteroidal anti-inflammatory drugs. Epidemiology 1995; 6:49-54.
45. Krymchantowski AV, Silva MT. Intravenous lysine clonixinate for the acute treatment of severe migraine attacks: a double-blind, randomized, placebo-controlled study. Curr Therap Res Clin Exp 2003; 64(8):505-513.
46. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill 1996; 27: 617-657.
47. Peroutka SJ. Drugs effective in the treatment of migraine. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill 1996; 21:487-502.
48. Di Monda V, Nicolodi M, Aloisio A, et al. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache 2003; 43:835-844.
49. Pareja JA, Caminero AB, Franco E, et al. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001; 21(9):906-910.
50. Silberstein S, Tepper S, Brandes J, et al. Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine. Neurology 2004; 62:1552-1557.
51. Dahlof CG, Hargreaves RJ. Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies? Cephalalgia 1998; 18:593-604.
52. Tek DS, McClellan DS, Olshaker JS, Allen CL, Arthur DC. A prospective, doubleblind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990; 19:1083-1087.
53. Amery WK, Waelkens J. Prevention of the last chance: an alternative pharmacological treatment of migraine. Headache 1983; 23:37-38.
54. Waelkens J. Dopamine blockade with domperidone. Bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984; 4:85-90.
55. Chabriat H, Joire JE, Danchot J, Grippon P, Bousser MG. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicenter, double-blind, placebo-controlled study. Cephalalgia 1994; 14:297-300.
56. Krymchantowski AV, Bigal ME, Lipton RB, Moreira PF. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study [abstr]. Headache 2004; 44:463.
57. Peroutka SJ. Dopamine and migraine. Neurology 1997; 49(3):650-656.
58. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 1997; 49(1):201-206.
59. Tfelt-Hansen P. Antiemetic, prokinetic, neuroleptic, and miscellaneous drugs in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:445-452.
60. Jones J, Sklar D, Dougherty J, White W. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 1989; 261:1174-1176.
61. McEwen J, O'Connor H, Dinsdale H. Treatment of migraine with intramuscular chlorpromazine. Ann Emerg Med 1987; 16:758-763.
62. Bruntton LL. Agents affecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon LW, Gilman AG, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw Hill, 1996:917-936.
63. Fozard J. Basic mechanisms of antimigraine drugs. Adv Neurol 1982; 33:295-307.
64. Friedman BW, Corbo J, Lipton RB, Bijur PE, Esses D, Solorzano C, Gallagher EJ. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005; 64(3):463-468.
65. Peroutka SJ. Beyond Monotherapy: Rational polytherapy in migraine. Headache 1998; 38:18-22.
66. Bates D, Ashford E, Dawson R, et al. Subcutaneous sumatriptan during the migraine aura. Neurology 1994; 44:1587-1592.
67. Visser WH, de Vriend RH, Jaspers NHWM, Ferrari MD. Sumatriptan-nonresponders: a survey in 366 migraine patients. Headache 1996; 36:471-475.
68. Dahlof CG. How does sumatriptan perform in clinical practice? Cephalalgia 1995; 15(suppl 15):21-28.
69. Visser WH, de Vriend RH, Jaspers NHWM, Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 1996; 47:46-51.
70. Krymchantowski AV, Adriano M, Fernandes D. Tolfenamic acid decreases migraine recurrence when used with sumatriptan. Cephalalgia 1999; 19(3):186-187.
71. Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 2000; 58(2-B):428-430.
72. Krymchantowski AV, Barbosa JS. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia 2002; 22(4): 309-312.
73. Krymchantowski AV, Bigal ME. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol 2004; 28; 4(1):10.
74. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: psychosis and anxiety. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon LW, Gilman AG, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw Hill, 1996:399-430.
75. Lasagna L, Dekornfeld J. Methotrimeprazine: a new phenothiazine derivative with analgesic properties. JAMA 1961; 178:887-890.
76. Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med 2002; 23(2):141-148.
77. Bell R, Montoya D, Shuaib A, Lee M. Comparative trial of three agents in the treatment of acute migraine. Ann Emerg Med 1990; 19:1079-1082.
78. Lane P, McLellan B, Baggoley C. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 1989; 18:360-365.
79. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 1995; 26:541-546.
80. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as a single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med 1996; 14:262-265.
81. Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK Jr. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med 1994; 24:237-241.
82. Monzillo HP, Nemoto PH, Costa AR, Sanvito WS. Acute treatment of migraine in emergency room: open comparative study between dexametasone and haloperidol. Preliminary results. Arq Neuropsiquiatr 2004; 62(2-B):513-518.
83. Gawel MJ, Szalai JF, Stiglick A, Aimola N, Weiner M. Evaluation of analgesic agents in recurring headache compared with other clinical pain models. Clin Pharmacol Ther 1990; 47:504-508.
84. Silberstein SD, McCrory DC. Opioids. In Diener HC, ed. Drug Treatment of Migraine and Other Headaches. Monogr Clin Neurosci 2000; 17:222-236.
85. Carasso RL, Yehuda S. The prevention and treatment of migraine with an analgesic combination. Br J Clin Pract 1984; 38:25-27.
86. Uzogara E, Sheehan DV, Manschreck TC, Jones KJ. A combination drug treatment for acute common migraine. Headache 1986; 26:231-236.
87. General Practitioner Research Group. Migraine treated with an antihistamine-analgesic combination. Practitioner 1973; 211:357-361.
88. Silberstein SD, Freitag FG, Rozen TD, et al. Tramadol HCl/acetaminophen versus placebo in the treatment of acute migraine pain [abstr]. Headache 2004; 44:464.
89. Diamond S, Freitag FG, Diamond ML, Urban G. Transnasal butorphanol in the treatment of migraine headache pain. Headache Quart 1992; 3:164-171.
90. Hoffert MJ, Couch JR, Diamond S, et al. Transnasal butorphanol in the treatment of acute migraine. Headache 1995; 35:65-69.
91. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E. Comparison of singledose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology 1989; 39:590-592.
92. Larkin GL, Prescott JE. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med 1992; 21:919-924.
93. Snow V, Weiss K, Wall EM, Mottur-Pilson C. American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute migraine and prevention of migraine headache. Ann Intern Med 2002; 137(10):840-849.
94. Lipton RB, Bigal ME, Goadsby PJ. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication-a review. Cephalalgia 2004; 24:321-332.
95. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(suppl 7):1-96.
96. DSMSG (Diclofenac-K/Sumatriptan Migraine Study Group). Acute treatment of migraine attacks: efficacy and safety of a non-steroidal anti-inflammatory drug, diclofe-nac-potassium in comparison to oral sumatriptan and placebo. Cephalalgia 1999; 19:232-240.
97. Dib M, Massiou H, Weber M, Henry P, Garcia-Acosta S, Bousser MG. Bi-Profenid Migraine Study Group. Efficacy of oral ketoprofen in acute migraine. A double-blind randomized clinical trial. Neurology 2002; 58:1660-1665.
98. OSAM (Oral Sumatriptan and Aspirin Plus Metoclopramide Comparative Study Group). A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 1992; 32:177-184.
99. Freitag FG, Cady R, DiSerio F, et al. Comparative study of isometheptene mucate, dichlorphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache 2001; 41:391-398.
100. Geraud G, Compagnon A, Rossi A. COZAM Study Group. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomized, three-attack study. Eur Neurol 2002; 47(2):88-98.
101. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol 1991; 31(5):314-322.
102. Diener HC, Jansen JP, Reches A, et al. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicenter, randomized, double-blind, placebo-controlled comparison. Eur Neurol 2002; 47(2): 99-107.
103. Lipton RB, Bigal ME, Rush S, Yekonsky J, Liberman JN, Bartleson JD. Migraine practice among neurologists. Neurology 2004; 62(11):1926-1931.
104. Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs. step care strategies for migraine. The Disability in Strategies of Care (DISC) Study. JAMA 2000; 284: 2599-2605.